Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO26721 | Apium graveolens | Species | Apiaceae | Eukaryota | TCM_Taiwan* | |||
NPO29579 | Arisaematis rhizoma | NA | NA | NA | TCMSP* | |||
NPO16472 | Ginkgo semen | Species | Ginkgoaceae | Eukaryota | TCMSP* | |||
NPO29695 | Gleditsiae spina | NA | NA | NA | TCMSP* | |||
NPO24476 | Phellodendron amurense | Species | Rutaceae | Eukaryota | TM-MC* | |||
NPO22242 | Phellodendron chinense | Species | Rutaceae | Eukaryota | TM-MC* | |||
NPO26538 | Phellodendron chinese | Species | Rutaceae | Eukaryota | TM-MC* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT114 | Cell Line | LoVo | Homo sapiens | EC50 | = | 940 | nM | 18047263 |
NPT114 | Cell Line | LoVo | Homo sapiens | CC50 | > | 200000 | nM | 18047263 |
NPT114 | Cell Line | LoVo | Homo sapiens | Ratio CC50/EC50 | > | 210 | 18047263 | |
NPT2 | Others | Unspecified | Activity | < | 0.5 | nM | 18047263 | |
NPT2 | Others | Unspecified | Ratio | = | 27.6 | 19604606 | ||
NPT48 | Individual Protein | Lysine-specific demethylase 4D-like | Homo sapiens | Potency | = | 5623.4 | nM | PubChem BioAssay data set |
NPT48 | Individual Protein | Lysine-specific demethylase 4D-like | Homo sapiens | Potency | = | 281.8 | nM | PubChem BioAssay data set |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 3548.1 | nM | PubChem BioAssay data set |
NPT282 | Individual Protein | MAP kinase ERK2 | Homo sapiens | Potency | = | 6309.6 | nM | PubChem BioAssay data set |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | Potency | = | 7943.3 | nM | PubChem BioAssay data set |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | Potency | = | 3981.1 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 1412.5 | nM | PubChem BioAssay data set | |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 18348.9 | nM | PubChem BioAssay data set | |
NPT208 | Individual Protein | Cytochrome P450 1A2 | Homo sapiens | AC50 | = | 1000 | nM | PubChem BioAssay data set |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | AC50 | = | 3981.07 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | IC50 | = | 0.5 | nM | 21864947 | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 9285 | nM | PubChem BioAssay data set | |
NPT135 | Individual Protein | Chromobox protein homolog 1 | Homo sapiens | Potency | 89125.1 | nM | PubChem BioAssay data set | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 5858.4 | nM | PubChem BioAssay data set | |
NPT217 | Individual Protein | Adenosine A2a receptor | Homo sapiens | IC50 | = | 1312 | nM | DrugMatrix in vitro pharmacology data |
NPT217 | Individual Protein | Adenosine A2a receptor | Homo sapiens | Ki | = | 737 | nM | DrugMatrix in vitro pharmacology data |
NPT261 | Individual Protein | Monoamine oxidase A | Homo sapiens | IC50 | = | 831 | nM | DrugMatrix in vitro pharmacology data |
NPT292 | Individual Protein | Serotonin 2c (5-HT2c) receptor | Homo sapiens | IC50 | = | 2356 | nM | DrugMatrix in vitro pharmacology data |
NPT292 | Individual Protein | Serotonin 2c (5-HT2c) receptor | Homo sapiens | Ki | = | 1234 | nM | DrugMatrix in vitro pharmacology data |
NPT367 | Cell Line | MDA-N | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT457 | Cell Line | BT-549 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | 90573.26 | nM | PubChem BioAssay data set | |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT396 | Cell Line | T47D | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT402 | Cell Line | Hs-578T | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 1122 | nM | PubChem BioAssay data set | ||
NPT101 | Individual Protein | Glucagon-like peptide 1 receptor | Homo sapiens | Potency | 1258.9 | nM | PubChem BioAssay data set | |
NPT1043 | Individual Protein | Glycoprotein hormones alpha chain | Homo sapiens | Potency | 5011.9 | nM | PubChem BioAssay data set | |
NPT66 | Individual Protein | Acetylcholinesterase | Electrophorus electricus | Inhibition | = | 14.28 | % | 23062825 |
NPT67 | Individual Protein | Cholinesterase | Equus caballus | Inhibition | = | 2.42 | % | 23062825 |
NPT2 | Others | Unspecified | Activity | = | 95.2 | % | 23291118 | |
NPT2 | Others | Unspecified | Activity | = | 92.2 | % | 23291118 | |
NPT2 | Others | Unspecified | Activity | = | 96.7 | % | 23291118 | |
NPT2 | Others | Unspecified | Activity | = | 106.9 | % | 23291118 | |
NPT2 | Others | Unspecified | Inhibition | = | 40 | % | 23291118 | |
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Inhibition | = | 103.1 | % | 23571415 |
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Inhibition | = | 86.89 | % | 23571415 |
NPT2 | Others | Unspecified | Potency | 3.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 47.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 7166.9 | nM | PubChem BioAssay data set | ||
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 11455.4 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 530.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 13.3 | nM | PubChem BioAssay data set | ||
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | 21192.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | AC50 | 631 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 5955.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 2113.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1678.5 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC262635 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9852 | High Similarity | NPC254010 |
0.9779 | High Similarity | NPC313036 |
0.9493 | High Similarity | NPC166858 |
0.9493 | High Similarity | NPC51146 |
0.9433 | High Similarity | NPC266743 |
0.9366 | High Similarity | NPC88445 |
0.9362 | High Similarity | NPC74539 |
0.9362 | High Similarity | NPC304443 |
0.9357 | High Similarity | NPC246903 |
0.9338 | High Similarity | NPC29638 |
0.9301 | High Similarity | NPC191104 |
0.9236 | High Similarity | NPC98028 |
0.9203 | High Similarity | NPC36414 |
0.9197 | High Similarity | NPC268081 |
0.9149 | High Similarity | NPC17262 |
0.913 | High Similarity | NPC253616 |
0.913 | High Similarity | NPC103001 |
0.911 | High Similarity | NPC131725 |
0.9085 | High Similarity | NPC208584 |
0.9071 | High Similarity | NPC28337 |
0.9071 | High Similarity | NPC470856 |
0.9058 | High Similarity | NPC472516 |
0.9021 | High Similarity | NPC190572 |
0.9014 | High Similarity | NPC225884 |
0.9 | High Similarity | NPC472515 |
0.9 | High Similarity | NPC136095 |
0.9 | High Similarity | NPC473209 |
0.8978 | High Similarity | NPC247743 |
0.8926 | High Similarity | NPC269495 |
0.8919 | High Similarity | NPC250769 |
0.8919 | High Similarity | NPC278010 |
0.8919 | High Similarity | NPC295608 |
0.8905 | High Similarity | NPC229646 |
0.8904 | High Similarity | NPC155882 |
0.8897 | High Similarity | NPC272194 |
0.8889 | High Similarity | NPC210826 |
0.8889 | High Similarity | NPC300267 |
0.8889 | High Similarity | NPC51641 |
0.8867 | High Similarity | NPC33320 |
0.8859 | High Similarity | NPC19860 |
0.8857 | High Similarity | NPC332594 |
0.8841 | High Similarity | NPC292998 |
0.8836 | High Similarity | NPC37208 |
0.8836 | High Similarity | NPC221868 |
0.8828 | High Similarity | NPC12148 |
0.8828 | High Similarity | NPC198427 |
0.8828 | High Similarity | NPC130581 |
0.8811 | High Similarity | NPC53192 |
0.8808 | High Similarity | NPC169 |
0.8808 | High Similarity | NPC49009 |
0.8808 | High Similarity | NPC243509 |
0.88 | High Similarity | NPC270044 |
0.8776 | High Similarity | NPC135303 |
0.8776 | High Similarity | NPC148423 |
0.8767 | High Similarity | NPC306788 |
0.8767 | High Similarity | NPC135325 |
0.8759 | High Similarity | NPC473927 |
0.8759 | High Similarity | NPC154217 |
0.875 | High Similarity | NPC216092 |
0.875 | High Similarity | NPC14822 |
0.875 | High Similarity | NPC302181 |
0.8742 | High Similarity | NPC244750 |
0.8741 | High Similarity | NPC49852 |
0.8741 | High Similarity | NPC475496 |
0.8723 | High Similarity | NPC157855 |
0.8723 | High Similarity | NPC38153 |
0.8714 | High Similarity | NPC151113 |
0.8707 | High Similarity | NPC37226 |
0.8707 | High Similarity | NPC178202 |
0.8707 | High Similarity | NPC226644 |
0.8707 | High Similarity | NPC39929 |
0.8707 | High Similarity | NPC296030 |
0.8705 | High Similarity | NPC93756 |
0.8705 | High Similarity | NPC108113 |
0.8696 | High Similarity | NPC284424 |
0.869 | High Similarity | NPC171656 |
0.869 | High Similarity | NPC230943 |
0.869 | High Similarity | NPC1886 |
0.869 | High Similarity | NPC196137 |
0.8684 | High Similarity | NPC260296 |
0.8684 | High Similarity | NPC95472 |
0.8684 | High Similarity | NPC239270 |
0.8684 | High Similarity | NPC115432 |
0.8684 | High Similarity | NPC303210 |
0.8681 | High Similarity | NPC36181 |
0.8676 | High Similarity | NPC473907 |
0.8662 | High Similarity | NPC199458 |
0.8662 | High Similarity | NPC183639 |
0.8658 | High Similarity | NPC130015 |
0.8658 | High Similarity | NPC41326 |
0.8658 | High Similarity | NPC38361 |
0.8652 | High Similarity | NPC161196 |
0.8652 | High Similarity | NPC254741 |
0.8649 | High Similarity | NPC230713 |
0.8649 | High Similarity | NPC472406 |
0.8649 | High Similarity | NPC78335 |
0.8643 | High Similarity | NPC125920 |
0.8643 | High Similarity | NPC66705 |
0.8636 | High Similarity | NPC179464 |
0.8633 | High Similarity | NPC55147 |
0.863 | High Similarity | NPC181388 |
0.863 | High Similarity | NPC470322 |
0.8621 | High Similarity | NPC87609 |
0.8621 | High Similarity | NPC188632 |
0.8621 | High Similarity | NPC94794 |
0.8621 | High Similarity | NPC470296 |
0.8621 | High Similarity | NPC112791 |
0.8621 | High Similarity | NPC196459 |
0.8613 | High Similarity | NPC473894 |
0.8611 | High Similarity | NPC24075 |
0.8601 | High Similarity | NPC241975 |
0.8601 | High Similarity | NPC37206 |
0.8601 | High Similarity | NPC137009 |
0.8601 | High Similarity | NPC19476 |
0.86 | High Similarity | NPC41719 |
0.86 | High Similarity | NPC472462 |
0.8592 | High Similarity | NPC131782 |
0.8592 | High Similarity | NPC138047 |
0.8592 | High Similarity | NPC474624 |
0.8592 | High Similarity | NPC228661 |
0.8591 | High Similarity | NPC170169 |
0.8591 | High Similarity | NPC472407 |
0.8591 | High Similarity | NPC290671 |
0.8582 | High Similarity | NPC60667 |
0.8582 | High Similarity | NPC46869 |
0.8581 | High Similarity | NPC204088 |
0.8581 | High Similarity | NPC329215 |
0.8581 | High Similarity | NPC173149 |
0.8581 | High Similarity | NPC179015 |
0.8581 | High Similarity | NPC259007 |
0.8571 | High Similarity | NPC17816 |
0.8571 | High Similarity | NPC180477 |
0.8571 | High Similarity | NPC234536 |
0.8571 | High Similarity | NPC140120 |
0.8571 | High Similarity | NPC78612 |
0.8562 | High Similarity | NPC178627 |
0.8562 | High Similarity | NPC469935 |
0.8562 | High Similarity | NPC294365 |
0.8562 | High Similarity | NPC469953 |
0.8562 | High Similarity | NPC155144 |
0.8561 | High Similarity | NPC278556 |
0.8543 | High Similarity | NPC233776 |
0.8542 | High Similarity | NPC172986 |
0.8542 | High Similarity | NPC305355 |
0.8542 | High Similarity | NPC472409 |
0.8542 | High Similarity | NPC474037 |
0.8542 | High Similarity | NPC261227 |
0.8542 | High Similarity | NPC475680 |
0.8542 | High Similarity | NPC270883 |
0.8533 | High Similarity | NPC5871 |
0.8533 | High Similarity | NPC263676 |
0.8531 | High Similarity | NPC17848 |
0.8531 | High Similarity | NPC219584 |
0.8531 | High Similarity | NPC201395 |
0.8531 | High Similarity | NPC470083 |
0.8531 | High Similarity | NPC131130 |
0.8526 | High Similarity | NPC210460 |
0.8526 | High Similarity | NPC155264 |
0.8526 | High Similarity | NPC193881 |
0.8526 | High Similarity | NPC67450 |
0.8526 | High Similarity | NPC323137 |
0.8523 | High Similarity | NPC473466 |
0.8523 | High Similarity | NPC474660 |
0.8521 | High Similarity | NPC174999 |
0.8516 | High Similarity | NPC155640 |
0.8514 | High Similarity | NPC208303 |
0.8514 | High Similarity | NPC161864 |
0.8514 | High Similarity | NPC168085 |
0.8503 | High Similarity | NPC57470 |
0.85 | High Similarity | NPC54503 |
0.85 | High Similarity | NPC101294 |
0.85 | High Similarity | NPC182428 |
0.85 | High Similarity | NPC473655 |
0.8493 | Intermediate Similarity | NPC189650 |
0.8489 | Intermediate Similarity | NPC270369 |
0.8489 | Intermediate Similarity | NPC5515 |
0.8487 | Intermediate Similarity | NPC13879 |
0.8487 | Intermediate Similarity | NPC470625 |
0.8483 | Intermediate Similarity | NPC205006 |
0.8483 | Intermediate Similarity | NPC147688 |
0.8483 | Intermediate Similarity | NPC103362 |
0.8483 | Intermediate Similarity | NPC110969 |
0.8483 | Intermediate Similarity | NPC64908 |
0.8483 | Intermediate Similarity | NPC171870 |
0.8483 | Intermediate Similarity | NPC297985 |
0.8483 | Intermediate Similarity | NPC156590 |
0.8483 | Intermediate Similarity | NPC118840 |
0.8477 | Intermediate Similarity | NPC213608 |
0.8477 | Intermediate Similarity | NPC183874 |
0.8477 | Intermediate Similarity | NPC122365 |
0.8477 | Intermediate Similarity | NPC1477 |
0.8477 | Intermediate Similarity | NPC235333 |
0.8472 | Intermediate Similarity | NPC11566 |
0.8472 | Intermediate Similarity | NPC55018 |
0.8472 | Intermediate Similarity | NPC216978 |
0.8472 | Intermediate Similarity | NPC78913 |
0.8472 | Intermediate Similarity | NPC96565 |
0.8472 | Intermediate Similarity | NPC18260 |
0.8472 | Intermediate Similarity | NPC220062 |
0.8472 | Intermediate Similarity | NPC301217 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC262635 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD1243 | Approved |
0.9493 | High Similarity | NPD643 | Clinical (unspecified phase) |
0.9362 | High Similarity | NPD920 | Approved |
0.9357 | High Similarity | NPD642 | Clinical (unspecified phase) |
0.8867 | High Similarity | NPD919 | Approved |
0.8652 | High Similarity | NPD2796 | Approved |
0.8431 | Intermediate Similarity | NPD3749 | Approved |
0.8322 | Intermediate Similarity | NPD3748 | Approved |
0.8311 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.8298 | Intermediate Similarity | NPD1240 | Approved |
0.8269 | Intermediate Similarity | NPD1247 | Approved |
0.8243 | Intermediate Similarity | NPD6799 | Approved |
0.8235 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.8235 | Intermediate Similarity | NPD7819 | Suspended |
0.8224 | Intermediate Similarity | NPD7411 | Suspended |
0.8194 | Intermediate Similarity | NPD1510 | Phase 2 |
0.8188 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.8182 | Intermediate Similarity | NPD1607 | Approved |
0.817 | Intermediate Similarity | NPD6801 | Discontinued |
0.8151 | Intermediate Similarity | NPD1549 | Phase 2 |
0.8151 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.8095 | Intermediate Similarity | NPD2800 | Approved |
0.8082 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.8082 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.8082 | Intermediate Similarity | NPD2344 | Approved |
0.8077 | Intermediate Similarity | NPD7075 | Discontinued |
0.8041 | Intermediate Similarity | NPD3750 | Approved |
0.8039 | Intermediate Similarity | NPD6599 | Discontinued |
0.7945 | Intermediate Similarity | NPD2799 | Discontinued |
0.7902 | Intermediate Similarity | NPD1296 | Phase 2 |
0.7902 | Intermediate Similarity | NPD2313 | Discontinued |
0.7898 | Intermediate Similarity | NPD7768 | Phase 2 |
0.7891 | Intermediate Similarity | NPD1551 | Phase 2 |
0.7888 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.7887 | Intermediate Similarity | NPD6832 | Phase 2 |
0.7881 | Intermediate Similarity | NPD1511 | Approved |
0.7867 | Intermediate Similarity | NPD2309 | Approved |
0.7862 | Intermediate Similarity | NPD5494 | Approved |
0.7852 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7842 | Intermediate Similarity | NPD9717 | Approved |
0.7834 | Intermediate Similarity | NPD3817 | Phase 2 |
0.7829 | Intermediate Similarity | NPD2533 | Approved |
0.7829 | Intermediate Similarity | NPD2532 | Approved |
0.7829 | Intermediate Similarity | NPD2534 | Approved |
0.7826 | Intermediate Similarity | NPD3926 | Phase 2 |
0.7806 | Intermediate Similarity | NPD4380 | Phase 2 |
0.7801 | Intermediate Similarity | NPD1203 | Approved |
0.7778 | Intermediate Similarity | NPD1512 | Approved |
0.7778 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7771 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.777 | Intermediate Similarity | NPD422 | Phase 1 |
0.7722 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.7718 | Intermediate Similarity | NPD2343 | Clinical (unspecified phase) |
0.7718 | Intermediate Similarity | NPD1471 | Phase 3 |
0.7712 | Intermediate Similarity | NPD5401 | Approved |
0.7711 | Intermediate Similarity | NPD6559 | Discontinued |
0.7683 | Intermediate Similarity | NPD7893 | Clinical (unspecified phase) |
0.7682 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.7676 | Intermediate Similarity | NPD3266 | Approved |
0.7676 | Intermediate Similarity | NPD3267 | Approved |
0.7673 | Intermediate Similarity | NPD3882 | Suspended |
0.7671 | Intermediate Similarity | NPD4307 | Phase 2 |
0.7651 | Intermediate Similarity | NPD2935 | Discontinued |
0.7643 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.7628 | Intermediate Similarity | NPD3226 | Approved |
0.7626 | Intermediate Similarity | NPD17 | Approved |
0.7625 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.7622 | Intermediate Similarity | NPD1019 | Discontinued |
0.7619 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7616 | Intermediate Similarity | NPD2654 | Approved |
0.7613 | Intermediate Similarity | NPD5403 | Approved |
0.7613 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7595 | Intermediate Similarity | NPD1934 | Approved |
0.7547 | Intermediate Similarity | NPD2801 | Approved |
0.7545 | Intermediate Similarity | NPD5953 | Discontinued |
0.7517 | Intermediate Similarity | NPD1008 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD2798 | Approved |
0.7485 | Intermediate Similarity | NPD6959 | Discontinued |
0.7483 | Intermediate Similarity | NPD2346 | Discontinued |
0.747 | Intermediate Similarity | NPD3818 | Discontinued |
0.7467 | Intermediate Similarity | NPD4308 | Phase 3 |
0.7465 | Intermediate Similarity | NPD1608 | Approved |
0.745 | Intermediate Similarity | NPD6651 | Approved |
0.7439 | Intermediate Similarity | NPD6232 | Discontinued |
0.7439 | Intermediate Similarity | NPD6808 | Phase 2 |
0.7438 | Intermediate Similarity | NPD1465 | Phase 2 |
0.7431 | Intermediate Similarity | NPD2797 | Approved |
0.7425 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.7425 | Intermediate Similarity | NPD7286 | Phase 2 |
0.7425 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7415 | Intermediate Similarity | NPD3268 | Approved |
0.7415 | Intermediate Similarity | NPD411 | Approved |
0.741 | Intermediate Similarity | NPD7473 | Discontinued |
0.7399 | Intermediate Similarity | NPD4287 | Approved |
0.7391 | Intermediate Similarity | NPD5402 | Approved |
0.7383 | Intermediate Similarity | NPD447 | Suspended |
0.7383 | Intermediate Similarity | NPD1933 | Approved |
0.7375 | Intermediate Similarity | NPD6280 | Approved |
0.7375 | Intermediate Similarity | NPD6279 | Approved |
0.7372 | Intermediate Similarity | NPD1241 | Discontinued |
0.7353 | Intermediate Similarity | NPD4419 | Clinical (unspecified phase) |
0.7351 | Intermediate Similarity | NPD1509 | Clinical (unspecified phase) |
0.7346 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7338 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7338 | Intermediate Similarity | NPD4628 | Phase 3 |
0.731 | Intermediate Similarity | NPD1164 | Approved |
0.7284 | Intermediate Similarity | NPD2296 | Approved |
0.7284 | Intermediate Similarity | NPD4288 | Approved |
0.7278 | Intermediate Similarity | NPD1729 | Discontinued |
0.725 | Intermediate Similarity | NPD6585 | Discontinued |
0.7241 | Intermediate Similarity | NPD3225 | Approved |
0.7237 | Intermediate Similarity | NPD7033 | Discontinued |
0.7234 | Intermediate Similarity | NPD9545 | Approved |
0.7229 | Intermediate Similarity | NPD5710 | Approved |
0.7229 | Intermediate Similarity | NPD5711 | Approved |
0.7222 | Intermediate Similarity | NPD3972 | Approved |
0.7214 | Intermediate Similarity | NPD9493 | Approved |
0.7205 | Intermediate Similarity | NPD5889 | Approved |
0.7205 | Intermediate Similarity | NPD5890 | Approved |
0.72 | Intermediate Similarity | NPD943 | Approved |
0.7164 | Intermediate Similarity | NPD9697 | Approved |
0.7153 | Intermediate Similarity | NPD1281 | Approved |
0.7152 | Intermediate Similarity | NPD5124 | Phase 1 |
0.7152 | Intermediate Similarity | NPD230 | Phase 1 |
0.7152 | Intermediate Similarity | NPD5123 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD2403 | Approved |
0.7143 | Intermediate Similarity | NPD2353 | Approved |
0.7143 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD6166 | Phase 2 |
0.7143 | Intermediate Similarity | NPD2355 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.7126 | Intermediate Similarity | NPD7229 | Phase 3 |
0.7123 | Intermediate Similarity | NPD1876 | Approved |
0.7118 | Intermediate Similarity | NPD7054 | Approved |
0.7078 | Intermediate Similarity | NPD6100 | Approved |
0.7078 | Intermediate Similarity | NPD6099 | Approved |
0.7076 | Intermediate Similarity | NPD7472 | Approved |
0.7076 | Intermediate Similarity | NPD7074 | Phase 3 |
0.7067 | Intermediate Similarity | NPD3764 | Approved |
0.7052 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.7041 | Intermediate Similarity | NPD7784 | Clinical (unspecified phase) |
0.7035 | Intermediate Similarity | NPD6797 | Phase 2 |
0.7015 | Intermediate Similarity | NPD9261 | Approved |
0.7007 | Intermediate Similarity | NPD1283 | Approved |
0.7006 | Intermediate Similarity | NPD7003 | Approved |
0.6994 | Remote Similarity | NPD7251 | Discontinued |
0.6993 | Remote Similarity | NPD1548 | Phase 1 |
0.6981 | Remote Similarity | NPD7390 | Discontinued |
0.6962 | Remote Similarity | NPD3887 | Approved |
0.6962 | Remote Similarity | NPD2354 | Approved |
0.6961 | Remote Similarity | NPD8090 | Clinical (unspecified phase) |
0.6954 | Remote Similarity | NPD1699 | Clinical (unspecified phase) |
0.6954 | Remote Similarity | NPD7808 | Phase 3 |
0.6946 | Remote Similarity | NPD5537 | Clinical (unspecified phase) |
0.6944 | Remote Similarity | NPD1651 | Approved |
0.6937 | Remote Similarity | NPD7004 | Clinical (unspecified phase) |
0.6936 | Remote Similarity | NPD7993 | Clinical (unspecified phase) |
0.6929 | Remote Similarity | NPD5535 | Approved |
0.6918 | Remote Similarity | NPD1611 | Approved |
0.6918 | Remote Similarity | NPD1610 | Phase 2 |
0.6908 | Remote Similarity | NPD8032 | Phase 2 |
0.6906 | Remote Similarity | NPD4362 | Clinical (unspecified phase) |
0.6906 | Remote Similarity | NPD4361 | Phase 2 |
0.6894 | Remote Similarity | NPD6273 | Approved |
0.6894 | Remote Similarity | NPD5049 | Phase 3 |
0.6893 | Remote Similarity | NPD8434 | Phase 2 |
0.689 | Remote Similarity | NPD7615 | Clinical (unspecified phase) |
0.6875 | Remote Similarity | NPD6143 | Clinical (unspecified phase) |
0.6871 | Remote Similarity | NPD5808 | Clinical (unspecified phase) |
0.6871 | Remote Similarity | NPD7458 | Discontinued |
0.6864 | Remote Similarity | NPD7199 | Phase 2 |
0.6863 | Remote Similarity | NPD3142 | Approved |
0.6863 | Remote Similarity | NPD3140 | Approved |
0.6859 | Remote Similarity | NPD5408 | Approved |
0.6859 | Remote Similarity | NPD4477 | Approved |
0.6859 | Remote Similarity | NPD5405 | Approved |
0.6859 | Remote Similarity | NPD5404 | Approved |
0.6859 | Remote Similarity | NPD5406 | Approved |
0.6859 | Remote Similarity | NPD4476 | Approved |
0.6842 | Remote Similarity | NPD4907 | Clinical (unspecified phase) |
0.6835 | Remote Similarity | NPD1652 | Phase 2 |
0.6828 | Remote Similarity | NPD5691 | Approved |
0.6826 | Remote Similarity | NPD4947 | Clinical (unspecified phase) |
0.6818 | Remote Similarity | NPD6355 | Discontinued |
0.6815 | Remote Similarity | NPD6002 | Phase 3 |
0.6815 | Remote Similarity | NPD6005 | Phase 3 |
0.6815 | Remote Similarity | NPD6006 | Clinical (unspecified phase) |
0.6815 | Remote Similarity | NPD6004 | Phase 3 |
0.6815 | Remote Similarity | NPD6003 | Clinical (unspecified phase) |
0.6812 | Remote Similarity | NPD9263 | Approved |
0.6812 | Remote Similarity | NPD9264 | Approved |
0.6812 | Remote Similarity | NPD9267 | Approved |
0.6786 | Remote Similarity | NPD6971 | Discontinued |
0.6784 | Remote Similarity | NPD7184 | Clinical (unspecified phase) |
0.6784 | Remote Similarity | NPD5242 | Approved |
0.6781 | Remote Similarity | NPD1778 | Approved |
0.6776 | Remote Similarity | NPD4625 | Phase 3 |
0.677 | Remote Similarity | NPD7837 | Clinical (unspecified phase) |
0.6766 | Remote Similarity | NPD5353 | Approved |
0.6763 | Remote Similarity | NPD74 | Approved |
PubChem CID   | 5585 |
ChEMBL   | CHEMBL1475 |
ZINC   |
Molecular Weight:   | 228.08 |
ALogP:   | 1.6438 |
MLogP:   | 2.67 |
XLogP:   | 2.805 |
# Rotatable Bonds:   | 3 |
Polar Surface Area:   | 39.44 |
# H-Bond Aceptor:   | 1 |
# H-Bond Donor:   | 0 |
# Rings:   | 3 |
# Heavy Atoms:   | 17 |